A Tale of Two Experts
November 3, 2023, 9:15 AM
By: Ted Mathias
It was a tough day for opposing patent damages experts in Ecolab Inc. v. Dubois Chemicals, Inc., as Judge Andrews of the District of Delaware granted Daubert motions directed to both experts' reasonable royalty opinions. No. 21-567-RGA, 2023 WL 7019266 (D. Del. Oct. 25, 2023).
The patentee's expert had all of her patent damages opinions excluded because her royalty base included sales tied to noninfringing uses. When determining damages for a method claim, the patentee must limit damages in order to account for any noninfringing uses of an accused product. This “apportionment” is different from the paradigmatic apportionment involving a device with infringing and noninfringing features, but the law is clear that in both instances, apportionment is required.
The court's decision to strike an opinion of the opposing expert was straightforward but raises an interesting question about how the patentee approached its damages claim. The patentee put forth a reasonable royalty analysis grounded in the profits it allegedly would lose for the infringing sales - a lost profits analysis in all but name. It is unclear why the patentee did not simply seek lost profits for 50% of the infringing uses (based on its 50% market share) and a more traditional reasonable royalty on the other infringing uses. Based on the limited information disclosed in the opinion, that approach should have yielded a higher damages claim. One possibility is that the patentee was selling its product through a partner that did not have an exclusive license and thus lacked standing to claim lost profits as a separate measure of damages.
So what did the defendant's expert do wrong? He opined that his counterpart also should have used the defendant's market share (6.6%) in calculating Ecolab's losses and the corresponding royalty rate. As the court explained, that market share speaks to the royalty base of infringing uses but has no logical bearing on the royalty rate. In the court's words, “[i]t makes no methodological sense.”
Both sides now need to dig out from the wreckage. The patentee still has breach of contract damages it can pursue. Without an expert to present a patent damages opinion, the contract-based damages are likely the patentee's best bet.
Damages should be apportioned to separate out noninfringing uses, and patentees cannot recover damages based on sales of products with the mere capability to practice the claimed method. Rather, where the only asserted claim is a method claim, the damages base should be limited to products that were actually used to perform the claimed method.

To subscribe to our publications, click here.
News & Insights
News & Insights
ACI Forum on Pharma & Biotech Patent Litigation USA 2025
Speaking Engagement
Intellectual Property
CCWC 21st Annual Career Strategies Conference
Speaking Engagement
Fordham 52nd Annual Conference on International Antitrust Law and Policy
Speaking Engagement
Antitrust
Kisaco Research Trade Secret Legal Protection Conference 2025
Speaking Engagement
Intellectual Property
SCCE 23rd Annual Compliance & Ethics Institute
Speaking Engagement
Antitrust
29th Annual IBA Competition Conference
Sponsorship
Antitrust
Key Appellate Decisions Shaping Antitrust Strategy
Webinar
Antitrust
New Frontiers of Antitrust – 16th Annual International Conference of Concurrences Review
Speaking Engagement
Antitrust
MCCA Pathways Conference
Sponsorship
Antitrust
HNBA/VIA Annual Convention 2025
Sponsorship
Antitrust